GM
Geoff Meacham Citigroup Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
70
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
66.2%
Neutral
31%
Negative
2.8%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Technology
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Technology
Scientific & Technical Instruments
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $55 |
30%
upside
| 1 | +1.2% |
0
%
| 9 Jan ‘26 2 days ago |
|
|
|
Buy
Initiated
| $50 |
270%
upside
| 1 | +5.8% |
0
%
| 9 Jan ‘26 2 days ago |
|
|
|
Neutral
Maintained
| $180 |
4%
downside
| 4 | – |
–
| 7 Jan ‘26 4 days ago |
|
|
|
Buy
Maintained
| $140 |
16%
upside
| 2 | +1.9% |
0
%
| 7 Jan ‘26 4 days ago |
|
|
|
Neutral
Maintained
| $110 |
0%
downside
| 2 | – |
–
| 7 Jan ‘26 4 days ago |
|
|
|
Buy
Maintained
| $110 |
47%
upside
| 4 | +7% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $115 |
43%
upside
| 4 | +11% |
0
%
| 8 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $49 |
246%
upside
| 1 | -58% |
0
%
| 2 Dec ‘25 1 month ago |
|
|
|
Neutral
Reinstated
| $26 |
2%
upside
| 1 | – |
–
| 2 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $8 |
342%
upside
| 3 | +17% |
0
%
| 18 Nov ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $75 |
3%
downside
| 3 | – |
–
| 5 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $235 |
7%
upside
| 6 | +2.2% |
0
%
| 3 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $700 |
12%
downside
| 6 | +9.5% |
0
%
| 29 Oct ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| $72 |
1%
downside
| 6 | +11% |
0
%
| 27 Oct ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $28 |
18%
downside
| 2 | – |
–
| 23 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $50 |
45%
upside
| 2 | +39% |
0
%
| 17 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $50 |
17%
upside
| 2 | +41% |
0
%
| 17 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $20 |
64%
upside
| 4 | +27% |
0
%
| 17 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $93 |
73%
upside
| 2 | -8.3% |
0
%
| 17 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $575 |
24%
upside
| 1 | +15% |
0
%
| 2 Oct ‘25 3 months ago |
|
|
|
Buy
Upgraded
| $14 |
139%
upside
| 1 | +32% |
0
%
| 27 Aug ‘25 4 months ago |
|
|
|
Neutral
Maintained
| $310 |
5%
downside
| 3 | – |
–
| 6 Aug ‘25 5 months ago |
|
|
|
Buy
Maintained
| $42 |
5%
upside
| 1 | +13% |
0
%
| 22 Jul ‘25 5 months ago |
|
|
|
Buy
Maintained
| $54 |
30%
downside
| 1 | +74% |
0
%
| 25 Jun ‘25 6 months ago |
|
|
|
Buy
Initiated
| $110 |
66%
upside
| 1 | +3.4% |
0
%
| 17 Jun ‘25 6 months ago |
|